Cambridge Investment Research Advisors, Inc. Ionis Pharmaceuticals Inc Transaction History
Cambridge Investment Research Advisors, Inc.
- $27.1 Billion
- Q2 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 10,048 shares of IONS stock, worth $380,919. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,048
Previous 9,312
7.9%
Holding current value
$380,919
Previous $404,000
18.56%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding IONS
# of Institutions
395Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$525 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$479 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$391 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$313 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$249 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.38B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...